Researchers at Oregon State University have developed a new three-drug delivery system for cancer treatment, especially metastatic melanoma, the deadliest form of skin cancer – and shown that the system…
DetailsWe are proud that the editors of the Journal of Controlled Release have selected a new paper from SynVivo CTO, Prabhakar Pandian, Ph.D, and his colleagues as the cover of…
DetailsLeukocytes play a key role in early response to tissue injury/infection resulting from physical, chemical or biological stimuli. This process involves the initiation of the leukocyte adhesion cascade mediated by…
DetailsThe SynVivo® microfluidic cell-based assay platform has been recognized as one of the “Top 10 Innovations of 2013” by The Scientist magazine. SynVivo enables faster, more efficient drug development by combining the…
Details